in two double-blind , randomized cross-over comparison studies undertaken in elderly subjects , a new quinazoline derivative , prazosin , has been shown to be a safe and effective antihypertensive agent to which there is a progressive response over four- to six-week periods of oral administration at fixed dose-levels .
C0034407
quinazoline
C0032912
prazosin